Spots Global Cancer Trial Database for growth factor antagonist therapy

Every month we try and update this database with for growth factor antagonist therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Celecoxib in Preventing Skin Cancer	NCT00025051	Non-melanomatou...	celecoxib anti-cytokine t... antiangiogenesi... biological ther... cancer preventi... chemoprevention... growth factor a...	20 Years - 60 Years	National Cancer Institute (NCI)
S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix	NCT00072540	Stage 0 Cervica... High-grade Squa...	celecoxib anti-cytokine t... antiangiogenesi... biological ther... cancer preventi... chemoprevention... enzyme inhibito... growth factor a...	18 Years -	SWOG Cancer Research Network
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma	NCT00112879	Stage I Multipl... Stage II Multip... Stage III Multi... Refractory Plas...	arsenic trioxid... ascorbic acid dexamethasone thalidomide anti-cytokine t... antiangiogenesi... biological ther... chemotherapy drug resistance... growth factor a... non-specific im...	18 Years -	National Cancer Institute (NCI)
Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors	NCT00227773	Gastrointestina... Islet Cell Carc...	octreotide acet... vatalanib anti-cytokine t... antiangiogenesi... biological ther... endocrine thera... enzyme inhibito... growth factor a... hormone therapy protein tyrosin... somatostatin an...	18 Years - 120 Years	Eastern Cooperative Oncology Group
S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix	NCT00072540	Stage 0 Cervica... High-grade Squa...	celecoxib anti-cytokine t... antiangiogenesi... biological ther... cancer preventi... chemoprevention... enzyme inhibito... growth factor a...	18 Years -	SWOG Cancer Research Network
S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix	NCT00072540	Stage 0 Cervica... High-grade Squa...	celecoxib anti-cytokine t... antiangiogenesi... biological ther... cancer preventi... chemoprevention... enzyme inhibito... growth factor a...	18 Years -	SWOG Cancer Research Network
Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors	NCT00227773	Gastrointestina... Islet Cell Carc...	octreotide acet... vatalanib anti-cytokine t... antiangiogenesi... biological ther... endocrine thera... enzyme inhibito... growth factor a... hormone therapy protein tyrosin... somatostatin an...	18 Years - 120 Years	Eastern Cooperative Oncology Group
Celecoxib in Preventing Skin Cancer	NCT00025051	Non-melanomatou...	celecoxib anti-cytokine t... antiangiogenesi... biological ther... cancer preventi... chemoprevention... growth factor a...	20 Years - 60 Years	National Cancer Institute (NCI)
Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer	NCT00253526	Adenocarcinoma ... Recurrent Pancr... Stage I Pancrea... Stage II Pancre... Stage III Pancr...	bevacizumab gemcitabine hyd... adjuvant therap... anti-cytokine t... antiangiogenesi... antibody therap... biological ther... chemotherapy conventional su... growth factor a... monoclonal anti... surgery	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: